Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EBS | AMGN | VRTX | GILD | BMY |
| Company | Emergent Biosolutions | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 9.67 | 262.11 | 408.00 | 90.30 | 55.68 |
| High | 9.78 | 270.49 | 416.55 | 90.37 | 55.79 |
| Low | 9.25 | 261.28 | 397.24 | 89.02 | 54.81 |
| Last | 9.41 | 270.19 | 413.37 | 89.94 | 55.36 |
| Change | -0.47 | +7.96 | +3.81 | +0.06 | -0.47 |
| % Change | -4.76% | +3.04% | +0.93% | +0.07% | -0.84% |
| Volume | 699,600 | 3,365,900 | 1,859,700 | 6,523,200 | 7,120,700 |
| 20-Day Average Volume | 1,125,600 | 3,632,655 | 2,036,440 | 6,379,650 | 11,641,665 |
| Previous Close | 9.88 | 262.23 | 409.56 | 89.88 | 55.83 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.08 | 263.63 | 420.01 | 91.89 | 56.74 |
| 20-Day Raw Stochastic | 58.97% | 74.82% | 36.87% | 22.91% | 14.73% |
| 20-Day Relative Strength | 51.32% | 45.97% | 40.61% | 46.30% | 44.44% |
| Weighted Alpha | +65.01 | -15.18 | -9.90 | +12.07 | +14.91 |
| Today's Opinion | 88% Buy | 88% Sell | 88% Sell | 56% Buy | 40% Buy |
| Previous Opinion | 88% Buy | 100% Sell | 88% Sell | 56% Buy | 40% Buy |
| Last Month's Opinion | 24% Buy | 72% Sell | 8% Sell | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.82% since 01/03/25 | +3.43% since 01/03/25 | +1.54% since 01/03/25 | -1.61% since 01/03/25 | -2.14% since 01/03/25 |
| Low | 9.25 on 01/13/25 | 257.05 on 01/06/25 | 397.24 on 01/13/25 | 88.57 on 01/10/25 | 54.81 on 01/13/25 |
| High | 10.60 on 01/07/25 | 270.49 on 01/13/25 | 416.55 on 01/13/25 | 91.53 on 01/06/25 | 57.67 on 01/07/25 |
| 1-Month | |||||
| %Chg | +10.97% since 12/13/24 | -0.16% since 12/13/24 | -10.86% since 12/13/24 | -2.08% since 12/13/24 | -0.75% since 12/13/24 |
| Low | 7.70 on 12/20/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 88.57 on 01/10/25 | 54.81 on 01/13/25 |
| High | 10.60 on 01/07/25 | 272.69 on 12/16/24 | 474.18 on 12/17/24 | 94.55 on 12/26/24 | 58.54 on 12/18/24 |
| 3-Month | |||||
| %Chg | +7.54% since 10/11/24 | -17.71% since 10/11/24 | -14.19% since 10/11/24 | +5.87% since 10/11/24 | +6.05% since 10/11/24 |
| Low | 7.70 on 12/20/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 84.34 on 10/14/24 | 51.31 on 10/15/24 |
| High | 12.73 on 11/07/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | -11.64% since 07/12/24 | -18.33% since 07/12/24 | -15.42% since 07/12/24 | +28.56% since 07/12/24 | +36.83% since 07/12/24 |
| Low | 5.25 on 08/07/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 70.21 on 07/15/24 | 39.92 on 07/15/24 |
| High | 15.10 on 07/30/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 535,338 | 140,957,296 | 105,473,568 | 112,014,384 | 113,233,128 |
| Shares Outstanding, K | 54,184 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 1,049,300,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -760,500,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 293,800,000 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | 114,800,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 1.60 | 0.56 | 0.40 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.37 on 11/06/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 03/05/25 | 02/04/25 | 02/03/25 | 02/11/25 | 02/06/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 12/13/24 | 0.620 on 01/03/25 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 12/13/24 | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.75 | 0.00 | 20.12 | 48.56 |